JNANA THERAPEUTICS Trademark

Trademark Overview


On Friday, June 25, 2021, a trademark application was filed for JNANA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the JNANA THERAPEUTICS trademark a serial number of 90980184. The federal status of this trademark filing is REGISTERED as of Tuesday, September 12, 2023. This trademark is owned by Jnana Therapeutics Inc.. The JNANA THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; research and development in the medical fields, namely, small molecule pharmaceuticals; Pharmaceutical research and development of pharmaceutical preparations and substances that modulate historically undruggable targets across target classes, namely, solute carrier (SLC) metabolite transporters, transcription factors, signaling scaffolds and phosphatases to treat a range of diseases; pharmaceutical research and development of pharmaceutical preparations and substances that impact key immune pathways
jnana therapeutics

General Information


Serial Number90980184
Word MarkJNANA THERAPEUTICS
Filing DateFriday, June 25, 2021
Status700 - REGISTERED
Status DateTuesday, September 12, 2023
Registration Number7165147
Registration DateTuesday, September 12, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 8, 2022

Trademark Statements


Description of MarkThe mark consists of the word "JNANA" in a lowercase stylized font with a line over every letter besides "n" with the word "THERPEUTICS" directly below to the right.
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; research and development in the medical fields, namely, small molecule pharmaceuticals; Pharmaceutical research and development of pharmaceutical preparations and substances that modulate historically undruggable targets across target classes, namely, solute carrier (SLC) metabolite transporters, transcription factors, signaling scaffolds and phosphatases to treat a range of diseases; pharmaceutical research and development of pharmaceutical preparations and substances that impact key immune pathways

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 6, 2022
Primary Code042
First Use Anywhere DateThursday, December 14, 2017
First Use In Commerce DateThursday, December 14, 2017

Trademark Owner History


Party NameJnana Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameJnana Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameJnana Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Tuesday, September 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 12, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, August 9, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 8, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 21, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, July 20, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 29, 2023USE AMENDMENT FILED
Thursday, July 20, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, June 29, 2023DIVISIONAL REQUEST RECEIVED
Thursday, July 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 29, 2023TEAS REQUEST TO DIVIDE RECEIVED
Thursday, June 29, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, January 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 6, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, October 6, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 6, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, October 6, 2022EXAMINERS AMENDMENT -WRITTEN
Saturday, October 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 31, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 31, 2022NON-FINAL ACTION E-MAILED
Thursday, March 31, 2022NON-FINAL ACTION WRITTEN
Thursday, March 17, 2022ASSIGNED TO EXAMINER
Friday, September 10, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, September 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 29, 2021NEW APPLICATION ENTERED